Antipsychotic therapy of schizophrenia is a trigger of lipid metabolism disorders

The relevance of this problem is due to the significant increase in the prevalence of mental disorders, particularly schizophrenia, which represents one of the most complex issues in modern medicine. According to the World Health Organization (WHO), approximately 20 million people worldwide suffer from schizophrenia, and the socioeconomic costs of treating and rehabilitating patients continue to increase. Antipsychotic therapy remains the primary treatment for this category of patients; however, its use is accompanied by a number of serious side effects, among which metabolic disturbances occupy a prominent place. In this review article, the authors analyze the results of antipsychotic use by various researchers. The paper analyzes current scientific literature on the problem under study to establish the relationship between the efficacy of antipsychotic drugs and the occurrence of metabolic disturbances during their use, including long-term use. The authors conclude that it is necessary to determine lipid metabolism indicators during the use of drugs in this category.

Authors

Institutions

Publication Details

Journal
Вестник Новгородского государственного университета им. Ярослава Мудрого
Published
2026-11-19
DOI
https://doi.org/10.34680/2076-8052.2026.2(144).215-223
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antipsychotic therapy of schizophrenia is a trigger of lipid metabolism disorders

Aleksey E. Kim, Д.С. Богдашов, Н.Н. Максимюк
Вестник Новгородского государственного университета им. Ярослава Мудрого
Schizophrenia research and treatment
article

Antipsychotic therapy of schizophrenia is a trigger of lipid metabolism disorders

Aleksey E. Kim, Д.С. Богдашов, Н.Н. Максимюк
article en

Abstract

The relevance of this problem is due to the significant increase in the prevalence of mental disorders, particularly schizophrenia, which represents one of the most complex issues in modern medicine. According to the World Health Organization (WHO), approximately 20 million people worldwide suffer from schizophrenia, and the socioeconomic costs of treating and rehabilitating patients continue to increase. Antipsychotic therapy remains the primary treatment for this category of patients; however, its use is accompanied by a number of serious side effects, among which metabolic disturbances occupy a prominent place. In this review article, the authors analyze the results of antipsychotic use by various researchers. The paper analyzes current scientific literature on the problem under study to establish the relationship between the efficacy of antipsychotic drugs and the occurrence of metabolic disturbances during their use, including long-term use. The authors conclude that it is necessary to determine lipid metabolism indicators during the use of drugs in this category.

Вестник Новгородского государственного университета им. Ярослава Мудрого
S. M. Kirov Military Medical Academy (RU), Yaroslav-the-Wise Novgorod State University (RU)
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon